How Should Investors Position Themselves in This Year’s S&P 500 “Dark Horses” Moderna and Target? Apr 9, 2026 Consumer Goods, Life Science
Seeking Opportunities Amid U.S. Stock Market Volatility, These Two Healthcare Stocks Are Both Cheap and High-Yielding Apr 9, 2026 Life Science
Faced with Aggression from Medtronic and Johnson & Johnson, How Does Intuitive Surgical Defend Its Monopoly? Apr 8, 2026 Life Science
Wave Life Sciences’ Weight Loss Drug Phase 1 Clinical Data Triggers Stock Volatility, Yet Differentiated Path Still Shows Promise Apr 1, 2026 Life Science
Impressive Performance Yet Low Stock Price, Can Eli Lilly Usher in a Turning Point with Medicare Coverage? Mar 31, 2026 Life Science
Approved Catalyst Fuels Market Movement, Corcept Therapeutics Leads Healthcare Sector This Week Mar 27, 2026 Life Science
After Surging Over 100% in a Year, Executives Reduce Holdings Amid Adaptive Biotech’s Strong Performance Mar 27, 2026 Life Science
Under the Spotlight of GLP-1, the Hidden Risks of Eli Lilly’s High Valuation Cannot Be Ignored Mar 26, 2026 Life Science
After Five Years of Sluggish Performance, Pfizer Finds Renewed Hope in High Dividends and Clinical Data Mar 25, 2026 Life Science
A Pullback or a Buying Opportunity? Analyzing Vertex Pharmaceuticals’ Growth Drivers for the Coming Year Mar 25, 2026 Life Science
Who Will Be the Next Oncology Giant? Axsome and Madrigal Could Overtake by 2026 Mar 25, 2026 Life Science
